Roseline Vibert

发表

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic

F. Coulet, J. Gligorov, S. Richard, 2020, European Journal of Medical Genetics.

Next‐generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction

A. Vincent-Salomon, J. Cyrta, M. Nourieh, 2022, Histopathology.

Cancer risk and tumour spectrum in 172 patients with a germline SUFU pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group

Sandeep Kumar Dhanda, S. Pfister, P. Vahteristo, 2022, Journal of Medical Genetics.

AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer

J. Saurin, A. Hovnanian, B. Fournier, 2022, Genes, chromosomes & cancer.

Neurodevelopmental phenotype in 36 new patients with 8p inverted duplication–deletion: Genotype–phenotype correlation for anomalies of the corpus callosum

C. Garel, J. Andrieux, B. Delobel, 2021, Clinical genetics.

APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?

A. Vincent-Salomon, I. Bièche, V. Bécette, 2022, Journal of Medical Genetics.

Lynch syndrome: influence of additional susceptibility variants on cancer risk

P. Laurent-Puig, A. Duval, F. Coulet, 2023, European Journal of Human Genetics.

Molecular characterisation of tumours of the lacrimal apparatus.

A. Vincent-Salomon, S. Vacher, E. Girard, 2023, Histopathology.

Minors at risk of von Hippel-Lindau disease: 10 years’ experience of predictive genetic testing and follow-up adherence

S. Richard, V. Krivosic, A. Gimenez-Roqueplo, 2022, European Journal of Human Genetics.

Report of the sixth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Paris, France, November 16th 2022.

L. Guerrini-Rousseau, M. Jongmans, C. Haberler, 2024, Familial cancer.